Warhound, a U.S. company backed by prominent technology investors, has secured $200 million to develop genetically enhanced military dogs designed to detect explosives, assist in search-and-rescue missions and perform dangerous tasks for the U.S. military. The ambitious project has reached an estimated valuation of $1.2 billion, even though its first engineered dogs have yet to be born.
Warhound was launched by technology entrepreneurs Ben Lamm and Palmer Luckey. Lamm is known for co-founding Colossal Biosciences, a biotechnology company pursuing technologies aimed at bringing back extinct species, while Luckey founded Anduril Industries, a defense technology company.
According to reports published October 23 by the Financial Times and Wired, the project has attracted major investors, including Sequoia Capital, ARK Invest, Franklin Templeton and In-Q-Tel, an investment firm associated with the U.S. intelligence community.
Genetics Instead of Traditional Breeding
Warhound aims to combine cloning and genetic engineering to develop working dogs with improved health, greater endurance and enhanced sensory capabilities.
The company plans to use genetic material from high-performing working dogs, including Belgian Malinois and German Shepherds. Genetic interventions could initially focus on reducing inherited diseases, joint problems and vision disorders, with future research potentially targeting improved explosive-detection capabilities.
The dogs could also be equipped with specialized protective vests, sensors and communications systems developed by Anduril. The technology is intended to help military personnel monitor the animals’ movements and condition during operations.
U.S. Seeks to Reduce Reliance on European Suppliers
The project also addresses a supply-chain challenge facing the U.S. military. According to figures cited by Warhound, more than 80% of the working dogs used by the U.S. military come from Europe.
Fewer than half of the dogs acquired reportedly meet the required standards after an extensive selection and training process that can take approximately three years.
Warhound believes genetic technologies could improve the proportion of dogs that successfully complete training, reduce procurement costs and establish a more reliable domestic supply of military working dogs.
First Cloned Dogs Expected in 2027
According to the founders’ projections, the first cloned dogs could be born in early 2027, with potential military and law enforcement deployments being considered over the following two years.
The company has not yet disclosed the expected price of an individual genetically enhanced dog or demonstrated whether the technology can support economically viable production at scale.
The project also raises questions about animal welfare and the ethical boundaries of genetic engineering. Warhound has announced plans to work with American Humane to help establish standards for animal care and training.
The $200 million investment highlights growing interest among private investors in the intersection of biotechnology and defense. Ultimately, the project’s success will depend on whether Warhound can translate its scientific ambitions into a safe, effective and economically sustainable service.
